Caramiphen is an anticholinergic drug used in the treatment of Parkinson's disease.

[1] In combination with phenylpropanolamine it is used as a cough suppressant and nasal decongestant to treat symptoms associated with respiratory illnesses such as cold, allergies, hay fever, and sinusitis.

[2] It was added to the British National Formulary in 1963, with a dosage of 10 to 20 mg. Side effects include nausea, dizziness, and drowsiness.

This drug article relating to the nervous system is a stub.

You can help Wikipedia by expanding it.This drug article relating to the respiratory system is a stub.